Peptides DB
Research-centric peptide and protocol reference hub
Study 74 of 75Glutathione (GSH) literatureTalanta · Observational2027

Target-responsive "signal-down" electrochemical biosensor based on an anti-biofouling hydrogel for glutathione detection.

This study introduces a new biosensor for glutathione detection that may improve monitoring in complex biological environments, but detailed numeric outcomes are not provided.

Read at TalantaAdd to compare

Where it sits

this study against the rest of the glutathione (gsh) corpus
6
Preclinical
61
Observational · this one
0
Open-label
4
Randomised
4
Reviews

Summary and findings

This study presents a novel electrochemical biosensor designed for glutathione (GSH) detection, utilizing an anti-biofouling hydrogel. The biosensor was tested in vitro on B16 melanoma cells and normal L929 fibroblasts, as well as in a melanoma-bearing mouse model. The findings indicate the sensor's capability to differentiate GSH levels in these contexts.

How much of this paper we could read: full text read (0.70). We had a clear abstract, so the summary below closely tracks the paper. What this means →
Not reported in abstract.2027

Abstract

The authors’ words, as Talanta supplied them

Glutathione (GSH), a ubiquitous biothiol, is critical in physiological processes, and abnormal fluctuations in its level are intimately associated with various diseases. However, real-time in vivo monitoring of GSH within tissues, such as the tumor microenvironment (TME), is fundamentally hindered by severely electrode biofouling and electrochemical interference from structural analogs. Herein, we report a novel target-responsive "Signal-Down" electrochemical biosensor based on an anti-biofouling hydrogel for GSH detection, which elegantly integrates robust anti-biofouling capabilities with highly specific target recognition. This sensing interface features a highly hydrated polyacrylamide (PAM) network, crosslinked by disulfide bonds and loaded with ferrocene/β-cyclodextrin (Fc@β-CD) electroactive probes. Upon exposure to GSH, the highly specific thiol-disulfide exchange reaction triggers the macroscopic degradation of the Fc-hydrogel. This spatial disruption drives the rapid outward diffusion of the redox probes, translating microscopic molecular recognition into a dramatic attenuation of the electrochemical signal. This biosensor not only successfully differentiated abnormal intracellular GSH levels in B16 melanoma cells from those in normal L929 fibroblasts in vitro, but also achieved in situ detection of pathological redox dysregulation in a melanoma-bearing mouse model. Ultimately, by uniquely coupling macroscopic material degradation with signal attenuation, this work establishes a reliable strategy for continuous, interference-free biosensing in highly complex and fouling-prone biological matrices.

Background

Not reported in abstract.

Methods

Not reported in abstract.

Results

Not reported in abstract.

Interpretation

Not reported in abstract.

Limitations

Not reported in abstract.

Elsewhere in the Glutathione (GSH) corpus

CApolipoprotein E4 Exacerbates Aβ Oligomer-Induced Synaptotoxicity through Promoting Autophagic Degradation of Glutathione Peroxidase 4biorxiv-preprint · Not reported in abstract.In vitroCLoss of Ferroptosis-suppressors Accelerates Breast Cancer Recurrence by Promoting Dormancy Exitbiorxiv-preprint · 2026 · Not reported in abstract.AnimalBMethylglyoxal/Glyoxalase-1/Glutathione Biomarker Panel for Long COVIDbiorxiv-preprint · 2026 · Individuals with LC exhibited approximately 200% higher MG compared to controls.HumanBThree-Dimensional Spheroid Culture Reveals Differential Ferroptosis Susceptibility in Human Ovarian Cancer Cellsbiorxiv-preprint · 2026 · Not reported in abstract.In vitroDIntegrative multi-omics decoding of the host response to Klebsiella pneumoniae infection reveals an itaconate-centred metabolic-immune axis and a spatially organised inflammatory programmebiorxiv-preprint · 2026 · 30-fold pulmonary itaconate accumulation.reviewCRapid microwave-assisted synthesis of ZnMn dual-atom nanozymes for cancer catalytic immunotherapy.Biomaterials · 2026 · suppress primary and distal tumors by approximately 90%Animal